trial
as of 2026-07-01Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients
NCTId NCT03708549
at a glance
Phase 4 · Unknown
Enrollment 100 (estimated)
Sponsored by Tianjin Anding Hospital
Primary completion 2023-10-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2021-12-01
Primary completion
2023-10-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Tianjin Anding HospitalLead Sponsor
Sites
1 total
Tianjin, China
Facts & assertions
4 sourced
Enrollment
100
Phase
PHASE4
Primary Completion Date
2023-10-01
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
company
indication